Cite
Cycling therapy with benralizumab and dupilumab for severe eosinophilic asthma with eosinophilic chronic rhinosinusitis and eosinophilic otitis media.
MLA
Hamada, Satoshi, et al. “Cycling Therapy with Benralizumab and Dupilumab for Severe Eosinophilic Asthma with Eosinophilic Chronic Rhinosinusitis and Eosinophilic Otitis Media.” Allergology International : Official Journal of the Japanese Society of Allergology, vol. 70, no. 3, July 2021, pp. 389–91. EBSCOhost, https://doi.org/10.1016/j.alit.2021.02.002.
APA
Hamada, S., Ogino, E., & Yasuba, H. (2021). Cycling therapy with benralizumab and dupilumab for severe eosinophilic asthma with eosinophilic chronic rhinosinusitis and eosinophilic otitis media. Allergology International : Official Journal of the Japanese Society of Allergology, 70(3), 389–391. https://doi.org/10.1016/j.alit.2021.02.002
Chicago
Hamada, Satoshi, Eriko Ogino, and Hirotaka Yasuba. 2021. “Cycling Therapy with Benralizumab and Dupilumab for Severe Eosinophilic Asthma with Eosinophilic Chronic Rhinosinusitis and Eosinophilic Otitis Media.” Allergology International : Official Journal of the Japanese Society of Allergology 70 (3): 389–91. doi:10.1016/j.alit.2021.02.002.